Indies Pharma Jamaica Limited (JMSE:INDIES)
Jamaica
· Delayed Price · Currency is JMD 2.800
0.00 (0.00%)
At close: Mar 6, 2026
Indies Pharma Jamaica Cash Flow Statement
Financials in millions JMD. Fiscal year is November - October.
Millions JMD. Fiscal year is Nov - Oct.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | 2020 - 2016 |
| Net Income | 181.29 | 221.18 | 213.06 | 220.79 | 167.87 | Upgrade
|
| Depreciation & Amortization | 65.87 | 61.44 | 60.16 | 56.84 | 53.73 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -3.07 | -1.88 | -2.4 | Upgrade
|
| Other Operating Activities | 79.05 | 92.74 | 69.7 | 59.07 | 62.95 | Upgrade
|
| Change in Accounts Receivable | -15.39 | 8.59 | -103.5 | -5.32 | 60.12 | Upgrade
|
| Change in Inventory | 92.46 | -78.19 | 5.13 | 47.09 | -76.08 | Upgrade
|
| Change in Accounts Payable | 121.9 | -26.01 | 29.26 | 3.03 | -31.49 | Upgrade
|
| Change in Income Taxes | -44.18 | -22.16 | 7.87 | - | -0.14 | Upgrade
|
| Change in Other Net Operating Assets | -117.19 | -7.57 | 0.88 | -64.39 | 131.91 | Upgrade
|
| Operating Cash Flow | 363.81 | 250.01 | 279.47 | 315.22 | 366.48 | Upgrade
|
| Operating Cash Flow Growth | 45.52% | -10.54% | -11.34% | -13.99% | - | Upgrade
|
| Capital Expenditures | -43.52 | -8.88 | -14.02 | -26.37 | -40.72 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 3.53 | 1.88 | 2.98 | Upgrade
|
| Sale (Purchase) of Intangibles | -32.98 | -19.98 | -62.44 | -61.68 | -202.93 | Upgrade
|
| Investment in Securities | - | - | 63.14 | 67.31 | 0.75 | Upgrade
|
| Other Investing Activities | 1.12 | 1.62 | 1.46 | 0.95 | 4.84 | Upgrade
|
| Investing Cash Flow | -75.38 | -27.24 | -8.33 | -17.92 | -235.09 | Upgrade
|
| Short-Term Debt Issued | 1.45 | - | 0.06 | - | - | Upgrade
|
| Long-Term Debt Issued | 1,000 | - | - | 3.43 | 0.6 | Upgrade
|
| Total Debt Issued | 1,001 | - | 0.06 | 3.43 | 0.6 | Upgrade
|
| Short-Term Debt Repaid | - | -0.29 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -848.31 | -41.76 | -46.35 | -48.16 | -46.63 | Upgrade
|
| Total Debt Repaid | -848.31 | -42.05 | -46.35 | -48.16 | -46.63 | Upgrade
|
| Net Debt Issued (Repaid) | 153.14 | -42.05 | -46.29 | -44.73 | -46.03 | Upgrade
|
| Common Dividends Paid | -179.89 | -146.58 | -150.98 | -150.58 | -146.58 | Upgrade
|
| Other Financing Activities | -61.95 | -63.8 | -56.35 | -56.2 | -61.37 | Upgrade
|
| Financing Cash Flow | -88.71 | -252.42 | -253.62 | -251.5 | -253.99 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | 0.45 | 0.1 | - | Upgrade
|
| Net Cash Flow | 199.73 | -29.65 | 17.98 | 45.89 | -122.59 | Upgrade
|
| Free Cash Flow | 320.3 | 241.13 | 265.45 | 288.85 | 325.76 | Upgrade
|
| Free Cash Flow Growth | 32.83% | -9.16% | -8.10% | -11.33% | - | Upgrade
|
| Free Cash Flow Margin | 28.44% | 20.80% | 25.15% | 30.82% | 38.47% | Upgrade
|
| Free Cash Flow Per Share | 0.24 | 0.18 | 0.20 | 0.22 | 0.24 | Upgrade
|
| Cash Interest Paid | 61.95 | 63.8 | 56.35 | 56.2 | 61.37 | Upgrade
|
| Cash Income Tax Paid | - | - | - | 0.32 | - | Upgrade
|
| Levered Free Cash Flow | 241.98 | 48.68 | 73.53 | 111.44 | -74.56 | Upgrade
|
| Unlevered Free Cash Flow | 281.17 | 88.97 | 115.27 | 149.24 | -31.46 | Upgrade
|
| Change in Working Capital | 37.6 | -125.34 | -60.38 | -19.6 | 84.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.